<DOC>
	<DOC>NCT00266357</DOC>
	<brief_summary>A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.</brief_summary>
	<brief_title>Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Patients with a diagnosis of primary insomnia Patients with an active psychiatric disorder other than primary insomnia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>